Topical lincomycin gel in acne vulgaris: a multicentric placebo controlled study.
dc.contributor.author | Sharma, A D | en_US |
dc.contributor.author | Gupte, P D | en_US |
dc.contributor.author | Sundaram, M | en_US |
dc.contributor.author | Janaki, V R | en_US |
dc.contributor.author | Rege, V L | en_US |
dc.contributor.author | Bilimoria, F E | en_US |
dc.contributor.author | Arora, J | en_US |
dc.date.accessioned | 2009-05-28T08:33:51Z | |
dc.date.available | 2009-05-28T08:33:51Z | |
dc.date.issued | 2003-07-24 | en_US |
dc.description.abstract | INTRODUCTION: Acne vulgaris is commonly treated with topical antibacterials. We evaluated lincomycin gel, a new topical formulation for mild to moderate acne. MATERIAL AND METHODS: A multicentric, randomized, double blind, placebo controlled, clinical trial was conducted with lincomycin hydrochloride in 2% gel form in 200 patients with grade II and grade III acne. The severity of acne lesions was noted at baseline and after 4 weeks. RESULTS: About 70% cases in the study group showed a good to excellent response, which was significantly more as compared to 23% in the placebo group. The frequency and severity of adverse reactions in the two groups were similar. CONCLUSION: Lincomycin hydrochloride gel is an effective and safe treatment option for mild to moderate acne vulgaris. | en_US |
dc.description.affiliation | Wallace Pharmaceutical Ltd., Mumbai. | en_US |
dc.identifier.citation | Sharma AD, Gupte PD, Sundaram M, Janaki VR, Rege VL, Bilimoria FE, Arora J. Topical lincomycin gel in acne vulgaris: a multicentric placebo controlled study. Indian Journal of Dermatology, Venereology and Leprology. 2003 Jul-Aug; 69(4): 271-3 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/52794 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.ijdvl.com | en_US |
dc.title | Topical lincomycin gel in acne vulgaris: a multicentric placebo controlled study. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1